Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Stem Cell Research

Free Subscription Articles published in Nat Med Retrieve available abstracts of 21 articles: HTML format

Single Articles

October 2025
1. GRECO V
   Shared responsibility and global progress in stem cell research.
   Nat Med. 2025 Oct 27. doi: 10.1038/s41591-025-03997.
   PubMed    
   
   
   July 2025
2. AGARWAL R, Bertaina A, Soco C, Long-Boyle JR, et al
   Irradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trial.
   Nat Med. 2025 Jul 22. doi: 10.1038/s41591-025-03817.
   PubMed     Abstract available
   
   
   
3. 
   Mapping circulating hematopoietic stem cells for non-invasive, blood-based diagnostics.
   Nat Med. 2025 Jul 10. doi: 10.1038/s41591-025-03803.
   PubMed    
   
   
   
4. GRIMLEY M, Davies SM, Shrestha A, Shova A, et al
   Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial.
   Nat Med. 2025;31:2204-2212.
   PubMed     Abstract available
   
   
   June 2025
5. CHEN JT, Dadheech N, Tan EHP, Ng NHJ, et al
   Stem cell therapies for diabetes.
   Nat Med. 2025 Jun 27. doi: 10.1038/s41591-025-03767.
   PubMed     Abstract available
   
   
   
6. FURER N, Rappoport N, Milman O, Tavor S, et al
   A reference model of circulating hematopoietic stem cells across the lifespan with applications to diagnostics.
   Nat Med. 2025 Jun 27. doi: 10.1038/s41591-025-03716.
   PubMed     Abstract available
   
   
   
7. HEALEY N
   Stem cell therapies advance in Parkinson's disease and beyond.
   Nat Med. 2025 Jun 4. doi: 10.1038/d41591-025-00036.
   PubMed    
   
   
   
8. MOLTENI R, Fiumara M, Campochiaro C, Alfieri R, et al
   Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.
   Nat Med. 2025;31:1911-1924.
   PubMed     Abstract available
   
   
   April 2025
9. O'LEARY K
   Progress with stem cell therapy in Parkinson's disease.
   Nat Med. 2025 Apr 30. doi: 10.1038/d41591-025-00029.
   PubMed    
   
   
   March 2025
10. RASH BG, Ramdas KN, Agafonova N, Naioti E, et al
    Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial.
    Nat Med. 2025 Mar 10. doi: 10.1038/s41591-025-03559.
    PubMed     Abstract available
    
    
    February 2025
11. MULLER A, Sullivan J, Schwarzer W, Wang M, et al
    High-efficiency base editing in the retina in primates and human tissues.
    Nat Med. 2025;31:490-501.
    PubMed     Abstract available
    
    
    December 2024
12. O'LEARY K
    Stem cells reverse type 1 diabetes.
    Nat Med. 2024;30:3393.
    PubMed    
    
    
    November 2024
13. 
    HIV-1 remission following stem cell transplant without CCR5Delta32 mutation.
    Nat Med. 2024 Nov 6. doi: 10.1038/s41591-024-03365.
    PubMed    
    
    
    October 2024
14. SVENDSEN SP, Svendsen CN
    Cell therapy for neurological disorders.
    Nat Med. 2024;30:2756-2770.
    PubMed     Abstract available
    
    
    
15. DIEZ-DIEZ M, Ramos-Neble BL, de la Barrera J, Silla-Castro JC, et al
    Unidirectional association of clonal hematopoiesis with atherosclerosis development.
    Nat Med. 2024;30:2857-2866.
    PubMed     Abstract available
    
    
    September 2024
16. SAEZ-CIRION A, Mamez AC, Avettand-Fenoel V, Nabergoj M, et al
    Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
    Nat Med. 2024 Sep 2. doi: 10.1038/s41591-024-03277.
    PubMed     Abstract available
    
    
    
17. CHEN X, Huang Y, Huang L, Huang Z, et al
    A brain cell atlas integrating single-cell transcriptomes across human brain regions.
    Nat Med. 2024;30:2679-2691.
    PubMed     Abstract available
    
    
    June 2024
18. CHEN YB, Mohty M, Zeiser R, Teshima T, et al
    Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial.
    Nat Med. 2024 Jun 6. doi: 10.1038/s41591-024-03016.
    PubMed     Abstract available
    
    
    May 2024
19. ZINTER MS, Dvorak CC, Mayday MY, Reyes G, et al
    Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.
    Nat Med. 2024 May 23. doi: 10.1038/s41591-024-02999.
    PubMed     Abstract available
    
    
    
20. KELLY K, Bloor AJC, Griffin JE, Radia R, et al
    Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease.
    Nat Med. 2024 May 22. doi: 10.1038/s41591-024-02990.
    PubMed     Abstract available
    
    
    
21. HOUOT R, Bachy E, Cartron G, Gros FX, et al
    Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
    Nat Med. 2024 May 14. doi: 10.1038/s41591-024-03053.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.